MENU
+Compare
EXEL
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$39.04
Change
+$0.35 (+0.90%)
Capitalization
10.51B

EXEL Exelixis Forecast, Technical & Fundamental Analysis

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EXEL with price predictions
Sep 26, 2025

EXEL in upward trend: 10-day moving average broke above 50-day moving average on September 24, 2025

The 10-day moving average for EXEL crossed bullishly above the 50-day moving average on September 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXEL advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 281 cases where EXEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EXEL as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EXEL moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EXEL broke above its upper Bollinger Band on September 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EXEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.168) is normal, around the industry mean (19.823). P/E Ratio (18.769) is within average values for comparable stocks, (53.778). Projected Growth (PEG Ratio) (2.598) is also within normal values, averaging (2.098). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (5.066) is also within normal values, averaging (349.540).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EXEL is expected to report earnings to fall 8.31% to 68 cents per share on November 04

Exelixis EXEL Stock Earnings Reports
Q3'25
Est.
$0.69
Q2'25
Beat
by $0.11
Q1'25
Beat
by $0.25
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.13
The last earnings report on July 28 showed earnings per share of 75 cents, beating the estimate of 63 cents. With 1.64M shares outstanding, the current market capitalization sits at 10.51B.
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXU190.5011.41
+6.37%
MicroSectors™ Gold Miners 3X Lvrgd ETN
CVMC63.140.68
+1.08%
Calvert US Mid-Cp Cor Rspnb ETF
IBCA25.960.04
+0.15%
iShares iBonds Dec 2035 Term Corp ETF
EAOM29.74N/A
N/A
iShares ESG Aware 40/60 Mod Allc ETF
JMSI50.13-0.03
-0.06%
JPMorgan Sustainable Municipal Inc ETF

EXEL and Stocks

Correlation & Price change

A.I.dvisor tells us that EXEL and ACLX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXEL and ACLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
+0.90%
ACLX - EXEL
31%
Poorly correlated
+1.72%
JAZZ - EXEL
30%
Poorly correlated
-0.63%
LQDA - EXEL
30%
Poorly correlated
-2.90%
RIGL - EXEL
29%
Poorly correlated
-0.24%
RVMD - EXEL
28%
Poorly correlated
+3.32%
More